北京英诺特生物技术股份有限公司

Innovita Biological Technology Co., Ltd. is a publicly listed diagnostics company focused on advancing precision healthcare through integrated technology platforms and innovative in vitro diagnostic (IVD) solutions.

Founded in 2006 and listed on the STAR Market of the Shanghai Stock Exchange (Stock Code: 688253), Innovita develops, manufactures, and commercializes diagnostic products serving clinical laboratories, healthcare providers, and patients worldwide.

Our innovation ecosystem is supported by six core technology platforms spanning immunodiagnostics, molecular diagnostics, recombinant protein engineering, cell and pathogen culture, and advanced assay development. These capabilities enable us to deliver comprehensive solutions across infectious diseases, respiratory diagnostics, gastrointestinal health, fertility, tropical diseases, and other healthcare applications.

Innovita's products have been distributed to more than 70 countries and regions, supporting a broad range of diagnostic needs through rapid testing, immunoassays, and molecular technologies.

Driven by scientific innovation, manufacturing excellence, and a commitment to quality, we continue to expand access to reliable diagnostics worldwide.

Diagnostics, Wherever Care is Needed.